Executive Summary
Misleading advertisements undermine consumer trust and market integrity. The Consumer Protection Act, 2019 empowers the Central Consumer Protection Authority (CCPA) to regulate advertising practices:
- Definition: False or misleading claims about goods/services - Section 2(28)
- Regulator: Central Consumer Protection Authority (CCPA)
- Powers: Cease and desist, corrective advertising, product recall
- Penalties: Up to Rs. 10 lakh (first); Rs. 50 lakh (subsequent)
- Endorser liability: Celebrities/influencers liable for false claims
- Due diligence: Endorsers must verify claims
- Endorsement ban: 1-3 years for repeated violations
This guide examines misleading advertisement regulations, CCPA enforcement, and endorser accountability.
1. Statutory Framework
Consumer Protection Act, 2019
| Provision |
Content |
| Section 2(28) |
Definition of misleading advertisement |
| Section 2(1) |
Definition of advertisement |
| Section 18 |
CCPA powers against misleading ads |
| Section 20 |
Inquiry procedure |
| Section 21 |
Penalty provisions |
2. Definition of Misleading Advertisement - Section 2(28)
Misleading Advertisement Means
An advertisement that:
| Element |
Description |
| (i) Falsely describes |
Incorrect claims about product/service |
| (ii) Gives false guarantee |
Unfounded assurances |
| (iii) Misleading likely |
Likely to deceive consumers |
Covers
| Aspect |
Scope |
| Nature |
Character of goods/services |
| Substance |
Composition, ingredients |
| Quantity |
Size, weight, volume |
| Quality |
Standard, grade |
3. Types of Misleading Advertisements
False Representation
| Type |
Examples |
| Efficacy claims |
"100% cure for diabetes" |
| Ingredient claims |
"All natural" when containing chemicals |
| Origin claims |
"Made in Switzerland" when made elsewhere |
| Approval claims |
"FDA approved" without approval |
| Endorsement claims |
"Recommended by doctors" without evidence |
Exaggerated Claims
| Type |
Examples |
| Performance |
"Lose 10 kg in 10 days" |
| Results |
"Guaranteed results" |
| Comparison |
"10x better than competition" without proof |
| Scientific claims |
"Scientifically proven" without studies |
Omission of Material Facts
| Omission |
Impact |
| Side effects |
Hiding adverse reactions |
| Limitations |
Not disclosing product limits |
| Conditions |
Hidden terms and conditions |
| Risks |
Not warning of dangers |
Bait Advertising
| Practice |
Description |
| Unavailable products |
Advertising products not genuinely for sale |
| Limited stock |
Without disclosing scarcity |
| Flash sales |
Creating artificial urgency |
| Bait-and-switch |
Advertising one, selling another |
4. CCPA Powers - Section 18
Preventive Powers
| Power |
Description |
| Inquiry |
Investigate misleading ads |
| Cease and desist |
Stop advertisement immediately |
| Product recall |
Withdraw unsafe products |
| Advertisement withdrawal |
Remove from all media |
| Corrective advertisement |
Publish corrected information |
| Disclosure order |
Mandate disclosure of facts |
Investigation Powers
| Power |
Description |
| Call for information |
From advertiser, endorser, publisher |
| Inspection |
Of premises, records |
| Summon witnesses |
Examination on oath |
| Document production |
Compel submission of evidence |
| Expert opinion |
Seek technical/scientific views |
5. CCPA Inquiry Procedure - Section 20
Initiation
| Mode |
Trigger |
| Suo motu |
CCPA's own knowledge |
| Consumer complaint |
Individual/group complaint |
| Reference |
From State Commission |
| Government direction |
Central Government |
Inquiry Process
| Stage |
Action |
| 1. Prima facie view |
Initial assessment |
| 2. Notice to parties |
Advertiser, manufacturer, endorser |
| 3. Reply opportunity |
Time to respond |
| 4. Hearing |
If required |
| 5. Evidence examination |
Documents, witnesses |
| 6. Order |
Finding and penalty |
6. Penalty Provisions - Section 21
Manufacturer/Service Provider Penalties
| Violation |
Penalty |
| First violation |
Up to Rs. 10 lakh |
| Subsequent violations |
Up to Rs. 50 lakh |
| Repetitive conduct |
Prohibition + penalty |
Advertiser Penalties
| Entity |
Penalty |
| Advertising agency |
Up to Rs. 10 lakh (first) |
| Repeat violation |
Up to Rs. 50 lakh |
Endorser Penalties - Section 21(4)
| Violation |
Penalty |
| No due diligence |
Up to Rs. 10 lakh (first) |
| Subsequent violations |
Up to Rs. 50 lakh |
| Endorsement ban |
1 year (first), up to 3 years (subsequent) |
7. Endorser Liability
Who is an Endorser
| Category |
Description |
| Celebrity |
Film stars, sports persons |
| Influencer |
Social media personalities |
| Expert |
Professionals, doctors, scientists |
| Common person |
Testimonial providers |
Endorser Obligations
| Obligation |
Description |
| Personal use/experience |
Must have used product/service |
| Verify claims |
Exercise due diligence |
| Expertise match |
Endorse within area of knowledge |
| Material connection disclosure |
Reveal financial interest |
| Ongoing monitoring |
Ensure continued accuracy |
8. Due Diligence by Endorser
What Constitutes Due Diligence
| Factor |
Requirement |
| Product trial |
Personal use before endorsement |
| Claim verification |
Review substantiation |
| Expert consultation |
Seek professional opinion |
| Material connection |
Disclose payment/benefit |
| Scientific evidence |
For health/safety claims |
Documentation
| Document |
Purpose |
| Product sample |
Evidence of personal use |
| Test reports |
Verification of claims |
| Expert opinion |
Supporting technical claims |
| Endorsement contract |
Terms of engagement |
No Due Diligence - Examples
| Scenario |
Violation |
| No product use |
Endorsing without trying |
| Blind endorsement |
Not verifying claims |
| False expertise |
Endorsing outside field |
| Hidden conflict |
Not disclosing financial interest |
9. Prohibition on Endorsement - Section 21(5)
Endorsement Ban
| Duration |
Violation |
| 1 year |
First violation |
| Up to 3 years |
Subsequent violations |
Scope of Ban
| Restriction |
Description |
| All endorsements |
Cannot endorse any product/service |
| All media |
TV, print, digital, social media |
| Direct and indirect |
Including brand ambassadorships |
Consequences of Violation
| Violation |
Penalty |
| Endorsing during ban |
Additional penalty |
| Extended ban |
Ban period may be extended |
| Contempt |
For willful violation |
10. Sector-Specific Issues
Health and Medical Products
| Practice |
Misleading Status |
| Disease cure claims |
"Cures cancer" - Prohibited |
| Guaranteed results |
"100% effective" - Misleading |
| No side effects |
Without evidence - False |
| Government approval claims |
Without actual approval - Prohibited |
Financial Products
| Practice |
Misleading Status |
| Guaranteed returns |
Without qualification - Misleading |
| Risk-free investments |
False representation |
| Unrealistic projections |
Past performance as guarantee - Misleading |
| Hidden charges |
Non-disclosure - Misleading |
Educational Services
| Practice |
Misleading Status |
| 100% placement |
Without substantiation - False |
| Guaranteed success |
Unqualified claims - Misleading |
| Fake accreditation |
Claiming non-existent approvals - Prohibited |
| Exaggerated faculty |
False credentials - Misleading |
11. Corrective Advertising
CCPA May Order
| Type |
Description |
| Retraction |
Withdraw misleading ad |
| Corrective statement |
Publish correction with same prominence |
| Apology |
Public apology in same media |
| Clarification |
Clarify misleading aspects |
| Cost |
At advertiser's expense |
Corrective Advertisement Requirements
| Requirement |
Description |
| Same media |
Where misleading ad appeared |
| Equal prominence |
Same size, time slot |
| Specified duration |
As directed by CCPA |
| Specific content |
CCPA-approved text |
12. Surrogate Advertising
Definition
Indirect advertising of prohibited products (alcohol, tobacco) through brand extensions.
Regulation
| Aspect |
Status |
| Alcohol ads |
Prohibited (Surrogate via music CDs, soda) |
| Tobacco ads |
Completely prohibited |
| CCPA power |
Can take action on surrogate ads |
| Penalty |
Same as misleading advertisement |
Online Advertising Issues
| Issue |
Regulation |
| Influencer marketing |
Must disclose paid partnership |
| Native advertising |
Must be marked as "sponsored" |
| User-generated content |
Brand responsible if sponsored |
| Targeting |
Cannot exploit vulnerable groups |
Disclosure Requirements
| Disclosure |
Format |
| Paid partnership |
Clear label (#ad, #sponsored) |
| Material connection |
Reveal financial relationship |
| Product placement |
Disclose if paid |
14. Defense Against Misleading Advertisement Claims
Valid Defenses
| Defense |
Basis |
| Truthful claims |
Claims are accurate and substantiated |
| Puffery |
General praise, not specific claims |
| Opinion |
Subjective views, not factual claims |
| Prior approval |
Regulatory approval obtained |
| Due diligence (endorser) |
Reasonable verification done |
Burden of Proof
| Stage |
Burden On |
| Prima facie misleading |
CCPA |
| Substantiation |
Advertiser must prove claims |
| Due diligence |
Endorser must prove |
15. Comparative Advertising
Permissible Comparison
| Requirement |
Description |
| Truthful |
Claims must be accurate |
| Verifiable |
Evidence-based |
| Material aspects |
Relevant product features |
| Not disparaging |
No false competitor claims |
Prohibited Practices
| Practice |
Description |
| False comparison |
Misleading competitor references |
| Selective comparison |
Cherry-picking favorable aspects |
| Denigration |
Unfairly criticizing competitor |
| Trademark misuse |
Using competitor mark improperly |
16. Recent Guidelines and Enforcement
CCPA Guidelines (2020)
| Guideline |
Focus Area |
| Endorsement Guidelines |
Celebrity/influencer responsibility |
| Health claims |
Stricter scrutiny |
| E-commerce advertising |
Platform accountability |
Recent Enforcement Actions
| Action |
Example |
| Penalty notices |
Against misleading health product ads |
| Corrective ads |
Directed for false claims |
| Endorser warnings |
To celebrities for inadequate diligence |
17. Compliance Checklist
For Advertisers/Manufacturers
For Endorsers
For Advertising Agencies
18. Key Takeaways for Practitioners
Broad Definition: Section 2(28) covers wide range of false/misleading claims.
CCPA as Regulator: Proactive enforcement against misleading ads.
Endorser Liability: Celebrities/influencers personally liable for false claims.
Due Diligence Mandatory: Endorsers must verify before endorsing.
Heavy Penalties: Up to Rs. 50 lakh plus endorsement ban.
Burden on Advertiser: To substantiate claims made.
Corrective Advertising: CCPA can mandate public corrections.
Conclusion
Misleading advertisement regulation under the Consumer Protection Act, 2019 represents a significant shift toward proactive consumer protection. The CCPA's powers to investigate, penalize, and ban endorsements create strong deterrents against deceptive advertising. Endorser liability provisions ensure celebrities and influencers exercise due diligence before lending credibility to products. Understanding what constitutes misleading advertisement, CCPA enforcement powers, and endorser obligations is critical for advertisers to ensure compliance and avoid substantial penalties and reputational damage.
